Esnault V L, Potiron-Josse M, Testa A, Ginet J D, Le Carrer D, Guenel J
Service de Néphrologie-Immunologie Clinique, CHR Nantes, France.
Nephron. 1991;58(4):437-42. doi: 10.1159/000186476.
Strenuous physical exercise causes transient proteinuria and renal hemodynamic changes: decrease of renal blood flow and to a lesser extent of the glomerular filtration rate, and an increase of the filtration fraction. However, the mechanisms of these modifications are still poorly understood. In order to elucidate them we performed maximal exercise tests on 8 untrained healthy volunteers after inhibition of the renin-angiotensin system (RAS) by captopril, the sympathetic nervous system by a beta-blocking drug (acebutolol) or an alpha-blocking drug (prazosin) and the prostaglandin system by indomethacin. Urinary albumin excretion was measured in every subject first at rest (AB) and then after exercise (AA) performed successively without and with blockade by each of theses drugs. AA-AB difference in the captopril test (12.04 +/- 6.11 micrograms/min) compared to that in the control test (68.91 +/- 25.18 micrograms/min) was significantly reduced (p less than 0.02). This difference remained unchanged after acebutolol (59.87 +/- 21.91 micrograms/min, p = 0.62), prazosin (35.23 +/- 27.80 micrograms/min, p = 0.21) and indomethacin (55.21 +/- 28.43 micrograms/min, p = 0.35). There was a negative correlation between the lowering of AA elevation and the rise in plasma renin activity in the captopril test (r = 0.64; p less than 0.03). Only acebutolol decreased systolic blood pressure significantly. These results suggest that the RAS plays a major role in postexercise proteinuria. We hypothesize that stimulation of this system induces an increase of efferent glomerular artery constriction and consequently of glomerular transcapillary pressure and the filtration fraction. Captopril seems able to prevent these hemodynamic changes.
肾血流量减少,肾小球滤过率在较小程度上降低,滤过分数增加。然而,这些改变的机制仍知之甚少。为了阐明这些机制,我们对8名未经训练的健康志愿者进行了最大运动试验,试验前分别用卡托普利抑制肾素 - 血管紧张素系统(RAS)、用β受体阻滞剂(醋丁洛尔)或α受体阻滞剂(哌唑嗪)抑制交感神经系统、用吲哚美辛抑制前列腺素系统。在每位受试者静息时(AB)以及在依次不使用和使用这些药物进行阻断的情况下运动后(AA)测量尿白蛋白排泄量。与对照试验(68.91±25.18微克/分钟)相比,卡托普利试验中AA - AB的差值(12.04±6.11微克/分钟)显著降低(p<0.02)。在使用醋丁洛尔(59.87±21.91微克/分钟,p = 0.62)、哌唑嗪(35.23±27.80微克/分钟,p = 0.21)和吲哚美辛(55.21±28.43微克/分钟,p = 0.35)后,该差值保持不变。在卡托普利试验中,AA升高的降低与血浆肾素活性的升高之间存在负相关(r = 0.64;p<0.03)。只有醋丁洛尔显著降低了收缩压。这些结果表明,RAS在运动后蛋白尿中起主要作用。我们推测该系统的刺激会导致出球小动脉收缩增加,从而导致肾小球跨毛细血管压力和滤过分数增加。卡托普利似乎能够预防这些血流动力学变化。